Mental health issues have been on the minds of many as athletes are under tremendous pressure to perform perfectly at the Olympics, and Filament Health is on a mission to get safe, natural psychedelics into the hands of everyone who needs them as soon as possible. Today's guest is Ben Lightburn, CEO and Co-Founder of Filament Health, an exclusively natural psychedelic drug development company. Ben talks about rapidly discovering and extracting natural pharmaceuticals. Ben is an entrepreneur specializing in the research, development, and commercialization of novel extraction technologies. He applies his background in botanical extraction to this emerging class of medicines. Filament Health is building a platform to support the treatment of mental health conditions through GMP-compliant and FDA-approved psychedelic extracts from lab-grown and regeneratively harvested plants. Key Takeaways:Insights on building a core team comfortable with operating in a startup environmentApproach to patenting and clinical trial process, as well as regulations for psychedelicsCommon misconceptions about natural pharmaceuticalsShow Notes: Filament HealthFilament Health - About UsFilament Health - Our TechnologyGood Manufacturing Practice (GMP)U.S. Food and Drug Administration (FDA)FDA - Breakthrough TherapyU.S. Drug Enforcement Administration (DEA)Health CanadaMazza InnovationApplication to be on the show: From Lab to LaunchQualioMusic by keldezQualio website:https://www.qualio.com/ Previous episodes:https://www.qualio.com/from-lab-to-launch-podcast Apply to be on the show:https://forms.gle/uUH2YtCFxJHrVGeL8 Music by keldez